𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CS6 TREATMENT OF INSTITUTIONALIZED PATIENTS WITH ALZHEIMER'S DISEASE WITH QUETIAPINE: A COST-EFFECTIVENESS EVALUATION

✍ Scribed by D Getsios; J O'Brien; JJ Caro; J Pesa

Book ID
119593530
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
59 KB
Volume
8
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of timed bright light treatment f
Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease
✍ Glenna A. Dowling; Judy Mastick; Erin M. Hubbard; Jay S. Luxenberg; Robert L. Bu πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 67 KB

Background Disturbances in rest-activity rhythm are prominent and disabling symptoms in Alzheimer's disease (AD). Nighttime sleep is severely fragmented and daytime activity is disrupted by multiple napping episodes. In most institutional environments, light levels are very low and may not be suffic

Akathisia as a side effect of antipsycho
Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease
✍ Christian Prueter; Benedikt Habermeyer; Christine Norra; Christoph M. Kosinski πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 43 KB πŸ‘ 1 views

## Abstract Due to its low profile for extrapyramidal side‐effects, quetiapine has become an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease (PD). We describe the case of a patient with PD who developed severe akathisia, a common complication